1. Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer
   Ilaria Alborelli et al, 2020, The Journal of Pathology CrossRef
2. Immunogenomics: steps toward personalized medicines
   Fokhrul Hossain et al, 2020, Clinical Precision Medicine CrossRef
3. The era of immunogenomics/immunopharmacogenomics
   Makda Zewde et al, 2018, Journal of Human Genetics CrossRef
4. Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer
   Tatsuo Matsuda et al, 2018, Clinical Cancer Research CrossRef
5. The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
   Frederik van Delft et al, 2020, Cancers CrossRef